Download PDF
Synfacts 2023; 19(03): 0309
DOI: 10.1055/s-0042-1753318
Innovative Drug Discovery and Development

Potent and Selective PARP7 Inhibitor, KMR-206, Regulates IFN-I Signaling

Contributor(s):
Dirk Trauner
,
Yingfang Wang
› Further Information
    Permissions and Reprints

Key words

PARP7 inhibitor - IFN-I signaling - immune-oncology


Publication History

Article published online:
13 February 2023

© 2023. Thieme. All rights reserved

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany